Inositol for PCOS Insulin Resistance: What the Evidence Shows

What is inositol and why does PCOS make it relevant?

Inositol is a sugar-like molecule your body produces and also obtains from food. It plays a role in insulin signaling — specifically in how cells respond to insulin and take up glucose. In PCOS, insulin resistance is common: cells do not respond normally to insulin, which causes the pancreas to produce more of it. Elevated insulin, in turn, can raise androgen (male hormone) levels, disrupt ovulation, and drive several of the hallmark features of PCOS 1Ref 1Teede HJ, Tay CT, Laven JJE, Dokras A, et al. (2023).Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.Current international PCOS guidelines' stance on inositol as investigational and the role of insulin resistance in PCOS.

Two forms are discussed most often in PCOS research: myo-inositol (MI) and D-chiro-inositol (DCI). They are structurally related but play different roles in insulin signaling pathways. Myo-inositol is more abundant in the body and has been studied more extensively for reproductive outcomes in PCOS.

What does the research actually show?

The evidence base consists largely of small randomized trials, many with short follow-up periods. The general findings include:

• Insulin markers: Several trials show myo-inositol can reduce fasting insulin levels and improve the HOMA-IR index, a measure of insulin resistance, compared to placebo. The reductions are meaningful but moderate.
• Ovulation and menstrual regularity: Some trials report improved ovulation rates and more regular cycles in women with PCOS who are anovulatory. Effect sizes vary across studies.
• Androgen levels: Some data suggest modest reductions in free testosterone and improvements in related symptoms such as hirsutism.
• Fertility: A small number of trials in women undergoing ovarian stimulation for assisted reproduction show potentially improved egg quality with myo-inositol supplementation, though the evidence is preliminary.

The 2023 international evidence-based PCOS guideline, which is the most current comprehensive review, acknowledges the emerging data on inositol but stops short of recommending it as a standard treatment 1Ref 1Teede HJ, Tay CT, Laven JJE, Dokras A, et al. (2023).Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.Current international PCOS guidelines' stance on inositol as investigational and the role of insulin resistance in PCOS. It notes the field needs larger, well-powered trials with consistent dosing and endpoints before strong conclusions can be drawn.

How does inositol compare to metformin?

Metformin is a prescription medication with a well-established evidence base for improving insulin resistance in PCOS and for reducing the risk of type 2 diabetes 2Ref 2Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group (2002).Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.Metformin's established evidence base for insulin resistance and diabetes prevention. The Endocrine Society clinical practice guideline for PCOS (2013) supports metformin as a therapeutic option for metabolic and menstrual outcomes 3Ref 3Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK (2013).Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.Endocrine Society guideline supporting metformin for metabolic and menstrual PCOS outcomes.

Direct head-to-head trials comparing myo-inositol to metformin have been conducted, but most are small, and the evidence for equivalence or superiority is not yet robust enough for a definitive conclusion. Some researchers have studied combining myo-inositol with DCI at a specific 40:1 ratio (mirroring the physiological ratio in the body), and combinations have been compared to metformin in small trials.

Metformin remains a medication approved and regulated by the FDA; inositol supplements are sold over the counter and are not regulated for efficacy or dosing by the FDA. That distinction matters for anyone comparing the two.

What current guidelines say about inositol in PCOS

The 2023 international evidence-based PCOS guideline 1Ref 1Teede HJ, Tay CT, Laven JJE, Dokras A, et al. (2023).Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.Current international PCOS guidelines' stance on inositol as investigational and the role of insulin resistance in PCOS and the Endocrine Society's earlier clinical practice guideline 3Ref 3Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK (2013).Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.Endocrine Society guideline supporting metformin for metabolic and menstrual PCOS outcomes both recognize inositol as an area of active research. The international guideline's stance is that the evidence is insufficient to recommend inositol over established treatments, but it acknowledges that some individuals may choose to use it and that the safety profile appears acceptable.

The ACOG Practice Bulletin on PCOS similarly focuses on lifestyle modification, combined oral contraceptives, and metformin as the mainstay of treatment for PCOS-related metabolic and reproductive concerns 4Ref 4American College of Obstetricians and Gynecologists (2018).ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome.ACOG focus on lifestyle, oral contraceptives, and metformin as standard PCOS treatments.

None of these guidelines prohibit inositol use, but none endorse it as a replacement for proven treatments.

Is inositol safe?

Inositol is generally well tolerated at doses studied in clinical trials, which typically range from 2 to 4 grams of myo-inositol per day. Reported side effects are mostly mild and gastrointestinal — nausea or loose stools at higher doses. No serious adverse effects have been identified in the available trial literature.

However, the supplement market is not regulated the same way prescription medications are. Product purity, actual dosing, and consistency vary by manufacturer. If you and your clinician decide to try inositol, choosing a product that has been third-party tested for purity is reasonable.

What is the right next step if you have PCOS and insulin resistance?

Insulin resistance in PCOS is best evaluated and managed in partnership with a clinician — typically an endocrinologist or a gynecologist who specializes in PCOS. The evaluation generally starts with fasting glucose, fasting insulin, HbA1c, and lipid panels to characterize your metabolic picture.

Lifestyle interventions — specifically, structured aerobic exercise and modest caloric restriction when weight loss is appropriate — remain the most consistently effective first step for improving insulin sensitivity in PCOS, and they carry no downside risks 1Ref 1Teede HJ, Tay CT, Laven JJE, Dokras A, et al. (2023).Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.Current international PCOS guidelines' stance on inositol as investigational and the role of insulin resistance in PCOS.

Inositol supplementation may be a reasonable add-on that you discuss with your clinician, particularly if metformin is not tolerated or not preferred, but it should not displace evaluation or proven treatments. Gale's primary care clinicians can help you understand your lab results, discuss your options, and coordinate with a specialist when appropriate.